28436990|t|TCRP1 promotes NIH/3T3 cell transformation by over-activating PDK1 and AKT1
28436990|a|Tongue cancer resistance-related protein 1 (TCRP1) gene was first cloned from the multidrug resistance tongue cancer cell (Tca8113 / pingyangmycin) in our lab. Our precious studies demonstrated that TCRP1 was involving in chemotherapy and radiotherapy resistance of tongue cancer cells, lung cancer cells and ovarian cancer cells. In this study, we showed that TCRP1 overexpression promotes cell transformation and tumorigenesis through hyperphosphorylation of the oncogenic kinase 3-phosphoinositide-dependent protein kinase-1 (PDK1) and AKT1, whereas inhibition of PDK1 by OSU-03012 or PDK1 small interfering RNA reversed TCRP1 -mediated cell transformation. Importantly, TCRP1 was able to directly interact with PDK1, and 93-107 amino-acid and 109-124 amino-acid sites of TCRP1 were the common binding domain of PDK1. Moreover, in line with its oncogenic activity, we found that TCRP1 is often overexpressed in human in lung cancer, glioma, ovarian cancer, thyroid cancer, nasopharyngeal carcinoma, pancreatic cancer, stomach cancer and tongue carcinoma tissues. Spearman correlation analysis showed that the expression of TCRP1 has a positive correlation with p-PDK1, as well as p-AKT1 in lung cancer and gliomas tissues. Thus, TCRP1 may be a candidate as human oncoprotein that promotes cancer development by activation of PDK1 / AKT1 signaling.
28436990	0	5	TCRP1	T116,T123	C3181276
28436990	15	27	NIH/3T3 cell	T025	C1257739
28436990	28	42	transformation	T043	C0040682
28436990	46	61	over-activating	T045	C1514559
28436990	62	66	PDK1	T116,T126	C0541150
28436990	71	75	AKT1	T116,T126	C0668624
28436990	76	131	Tongue cancer resistance-related protein 1 (TCRP1) gene	T028	C2681496
28436990	142	148	cloned	T059,T063	C0598888
28436990	158	178	multidrug resistance	T032	C0242640
28436990	179	192	tongue cancer	T191	C0153349
28436990	193	197	cell	T025	C0597032
28436990	199	206	Tca8113	T025	C0085983
28436990	209	222	pingyangmycin	T109,T195	C0053847
28436990	231	234	lab	T073,T093	C0022877
28436990	275	280	TCRP1	T028	C2681496
28436990	298	310	chemotherapy	T061	C3665472
28436990	315	327	radiotherapy	T061	C1522449
28436990	328	338	resistance	T169	C4281815
28436990	342	355	tongue cancer	T191	C0153349
28436990	356	361	cells	T025	C0597032
28436990	363	374	lung cancer	T191	C0242379
28436990	375	380	cells	T025	C0597032
28436990	385	399	ovarian cancer	T191	C0029925
28436990	400	405	cells	T025	C0597032
28436990	437	442	TCRP1	T116,T123	C3181276
28436990	443	457	overexpression	T045	C1514559
28436990	467	486	cell transformation	T043	C0040682
28436990	491	504	tumorigenesis	T191	C0007621
28436990	513	533	hyperphosphorylation	T044	C1158886
28436990	541	557	oncogenic kinase	T116,T126	C0031727
28436990	558	603	3-phosphoinositide-dependent protein kinase-1	T116,T126	C0541150
28436990	605	609	PDK1	T116,T126	C0541150
28436990	615	619	AKT1	T116,T126	C0668624
28436990	629	639	inhibition	T052	C3463820
28436990	643	647	PDK1	T116,T126	C0541150
28436990	651	660	OSU-03012	T109	C1569671
28436990	664	668	PDK1	T116,T126	C0541150
28436990	669	690	small interfering RNA	T114,T123	C1099354
28436990	700	705	TCRP1	T116,T123	C3181276
28436990	716	735	cell transformation	T043	C0040682
28436990	750	755	TCRP1	T116,T123	C3181276
28436990	791	795	PDK1	T116,T126	C0541150
28436990	808	818	amino-acid	T087	C0002518
28436990	831	847	amino-acid sites	T087	C0002518
28436990	851	856	TCRP1	T116,T123	C3181276
28436990	873	887	binding domain	T116,T123	C0242210
28436990	891	895	PDK1	T116,T126	C0541150
28436990	924	933	oncogenic	T116,T126	C0031727
28436990	934	942	activity	T045	C0599177
28436990	958	963	TCRP1	T116,T123	C3181276
28436990	973	986	overexpressed	T045	C1514559
28436990	990	995	human	T016	C0086418
28436990	999	1010	lung cancer	T191	C0242379
28436990	1012	1018	glioma	T191	C0017638
28436990	1020	1034	ovarian cancer	T191	C0029925
28436990	1036	1050	thyroid cancer	T191	C0549473
28436990	1052	1076	nasopharyngeal carcinoma	T191	C2931822
28436990	1078	1095	pancreatic cancer	T191	C0235974
28436990	1097	1111	stomach cancer	T191	C0699791
28436990	1116	1132	tongue carcinoma	T191	C0558353
28436990	1133	1140	tissues	T024	C0475358
28436990	1142	1171	Spearman correlation analysis	T062,T170	C0010101
28436990	1188	1198	expression	T045	C0017262
28436990	1202	1207	TCRP1	T116,T123	C3181276
28436990	1223	1234	correlation	T080	C1707520
28436990	1240	1246	p-PDK1	T116,T126	C0541150
28436990	1259	1265	p-AKT1	T116,T126	C0668624
28436990	1269	1280	lung cancer	T191	C0242379
28436990	1285	1292	gliomas	T191	C0017638
28436990	1293	1300	tissues	T024	C0475358
28436990	1308	1313	TCRP1	T116,T123	C3181276
28436990	1336	1341	human	T016	C0086418
28436990	1342	1353	oncoprotein	T116,T123	C0029005
28436990	1368	1374	cancer	T191	C0006826
28436990	1390	1400	activation	T045	C0599177
28436990	1404	1408	PDK1	T116,T126	C0541150
28436990	1411	1415	AKT1	T116,T126	C0668624
28436990	1416	1425	signaling	T044	C1148560